Combination Lipid Therapy in Type 2 Diabetes Michael Clearfield Clinical Trial Report 18 November 2010 Pages: 1 - 3
Statins in Combinations: From ARBITER-6 HALTS to ACCORD—What Works? Michael Clearfield Clinical Trial Report 16 November 2010 Pages: 4 - 8
A Potential Novel Therapeutic Addition to Statin Therapy for Dyslipidemia William B. Borden Clinical Trial Report 05 November 2010 Pages: 9 - 11
What Combination Therapy with a Statin, If Any, Would You Recommend? Carlos A. DujovneCraig D. WilliamsMatthew K. Ito ReviewPaper 24 November 2010 Pages: 12 - 22
Statin Rebound or Withdrawal Syndrome: Does It Exist? Andres PinedaLuigi X. Cubeddu ReviewPaper 23 November 2010 Pages: 23 - 30
Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP? Sridevi DevarajDavid SiegelIshwarlal Jialal ReviewPaper Open access 03 November 2010 Pages: 31 - 42
The Anti-Ischemic and Anti-Anginal Properties of Statins Joel A. LardizabalPrakash C. Deedwania ReviewPaper Open access 24 November 2010 Pages: 43 - 50
Approach to Dyslipidemia, Lipodystrophy, and Cardiovascular Risk in Patients with HIV Infection J. Gregory Troll ReviewPaper Open access 23 December 2010 Pages: 51 - 56
Statins and Renal Disease: Friend or Foe? Abhishek DeshmukhJawahar L. Mehta ReviewPaper 30 October 2010 Pages: 57 - 63
Are Cardiovascular Benefits in Statin Lipid Effects Dependent on Baseline Lipid Levels? Keith C. Ferdinand ReviewPaper 23 November 2010 Pages: 64 - 72
The Role of Red Yeast Rice for the Physician Ram Y. GordonDavid J. Becker ReviewPaper 09 November 2010 Pages: 73 - 80
Recombinant High-Density Lipoprotein Formulations Esad VucicRobert S. Rosenson ReviewPaper 06 November 2010 Pages: 81 - 87
Lipid Effects of Endocrine Medications Dan V. MihailescuAvni VoraTheodore Mazzone ReviewPaper 23 November 2010 Pages: 88 - 94
Therapies Targeting Exogenous Cholesterol Uptake: New Insights and Controversies Michael H. Davidson ReviewPaper 29 December 2010 Pages: 95 - 100